By expenditures
| Name | Title | Type |
|---|---|---|
| Kelly Pollard | Partner | Auditee |
| David Schaffert | PRESIDENT/CEO | Auditee |
| Martha Lindley | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 352001 | 2024 | 2025-03-31 | Miller Kaplan | $933,840 |
| 27061 | 2022 | 2023-03-29 | Lindley & Associates LLC | $1.01M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 27061 | 2022 | 2023-03-29 | 608792 | 2022-005 | - | - | A |
| 27061 | 2022 | 2023-03-29 | 608791 | 2022-004 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 608790 | 2022-003 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 608789 | 2022-002 | Material Weakness | - | A |
| 27061 | 2022 | 2023-03-29 | 608788 | 2022-001 | Significant Deficiency | - | A |
| 27061 | 2022 | 2023-03-29 | 608787 | 2022-005 | - | - | A |
| 27061 | 2022 | 2023-03-29 | 608786 | 2022-004 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 608785 | 2022-003 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 608784 | 2022-002 | Material Weakness | - | A |
| 27061 | 2022 | 2023-03-29 | 608783 | 2022-001 | Significant Deficiency | - | A |
| 27061 | 2022 | 2023-03-29 | 608782 | 2022-005 | - | - | A |
| 27061 | 2022 | 2023-03-29 | 608781 | 2022-004 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 608780 | 2022-003 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 608779 | 2022-002 | Material Weakness | - | A |
| 27061 | 2022 | 2023-03-29 | 608778 | 2022-001 | Significant Deficiency | - | A |
| 27061 | 2022 | 2023-03-29 | 32350 | 2022-005 | - | - | A |
| 27061 | 2022 | 2023-03-29 | 32349 | 2022-004 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 32348 | 2022-003 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 32347 | 2022-002 | Material Weakness | - | A |
| 27061 | 2022 | 2023-03-29 | 32346 | 2022-001 | Significant Deficiency | - | A |
| 27061 | 2022 | 2023-03-29 | 32345 | 2022-005 | - | - | A |
| 27061 | 2022 | 2023-03-29 | 32344 | 2022-004 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 32343 | 2022-003 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 32342 | 2022-002 | Material Weakness | - | A |
| 27061 | 2022 | 2023-03-29 | 32341 | 2022-001 | Significant Deficiency | - | A |
| 27061 | 2022 | 2023-03-29 | 32340 | 2022-005 | - | - | A |
| 27061 | 2022 | 2023-03-29 | 32339 | 2022-004 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 32338 | 2022-003 | - | - | N |
| 27061 | 2022 | 2023-03-29 | 32337 | 2022-002 | Material Weakness | - | A |
| 27061 | 2022 | 2023-03-29 | 32336 | 2022-001 | Significant Deficiency | - | A |